We thus investigated additional datasets comprising CNS tissue from MS patients, particularly focusing on those in which co-expressed networks containing CHD1L, FMO5, or PRKAB2 gene were detectable (Supplementary Data 11). This evidence concerns the gene FMO5 and myeloid sarcoma.